HeartSciences Inc. — Form 8-K
Filed November 19, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 92/100
What the filing says
HeartSciences Inc. (market cap ~$10.4M) entered an Equity Distribution Agreement dated November 18, 2026 with Maxim Group LLC to offer up to $50,000,000 of common stock on an at-the-market basis under Form S-3. The offering size is 4.8× the company's current market capitalization. Maxim will act as exclusive sales agent at a 2.5% commission (or 2.0% if Form S-3 limitations cease). No shares have been sold yet; the agreement permits continuous sales over three years, with the company controlling timing and pricing via transaction notices.
Why this rating
Massive capital raise capacity (5× company size) addresses likely cash constraints; transformational for microcap. Dilution risk and execution uncertainty offset upside potential.
Extracted items
- 4.02 non-reliance / restatement
Tradability signal
NO TRADE
No trade: price $0.06 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
at our read · unknown $0.06 | +10 min · unknown $0.06 ▲ 0.00% | +30 min · unknown $0.06 ▲ 0.00% | +1 hr · unknown $0.06 ▲ 0.00% | +4 hrs · unknown $0.06 ▲ 0.00% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.